Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the musculature (HP:0003011)help
Parent Node:
expand
Abnormal skeletal muscle morphology (HP:0011805)help
..Starting node
..expand
Decreased muscle mass (HP:0003199)help
Term ID: 3199
Name: Decreased muscle mass
Synonym: Decreased muscle mass
Definition:
Comments:
Reference: HP:0003199
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandAbnormal muscle fiber morphology (HP:0004303) help
..expandAbnormality of muscle size (HP:0030236) help
..expandCalcinosis (HP:0003761) help
..expandFatty replacement of skeletal muscle (HP:0012548) help
..expandFirm muscles (HP:0003725) help
..expandFlexion contracture (HP:0001371) help
..expandGeneralized muscular appearance from birth (HP:0003716) help
..expandIntramuscular hematoma (HP:0012233) help
..expandLevator palpebrae superioris atrophy (HP:0012241) help
..expandMuscular dystrophy (HP:0003560) help
..expandMuscular edema (HP:0100748) help
..expandMyopathy (HP:0003198) help
..expandMyositis (HP:0100614) help
..expandRhabdomyolysis (HP:0003201) help
..expandSkeletal muscle fibrosis (HP:0030951) help
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0003199HP:0003199Decreased muscle mass0AKT1 CL E G H207744Aortic valves stenosis of the childORPHA1758391164730
HP:0003199HP:0003199Decreased muscle mass0ALS2 CL E G H57679300605Juvenile amyotrophic lateral sclerosisCN239582ORPHA1947443606352
HP:0003199HP:0003199Decreased muscle mass0AP4E1 CL E G H23431613744Spastic paraplegia 51, autosomal recessive613744C3151056OMIM1509573607244
HP:0003199HP:0003199Decreased muscle mass0ASAH1 CL E G H427333ORPHA1913735613468
HP:0003199HP:0003199Decreased muscle mass0ATP6V0A2 CL E G H23545357074ORPHA161018481611716
HP:0003199HP:0003199Decreased muscle mass0ATP6V0A2 CL E G H235452834ORPHA161018481611716
HP:0003199HP:0003199Decreased muscle mass0ATP6V1A CL E G H523357074ORPHA1229851607027
HP:0003199HP:0003199Decreased muscle mass0ATP6V1E1 CL E G H529357074ORPHA1196857108746
HP:0003199HP:0003199Decreased muscle mass0CHRNE CL E G H1145608931Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency608931C1837091OMIM110111966100725
HP:0003199HP:0003199Decreased muscle mass0COLQ CL E G H8292603034Endplate acetylcholinesterase deficiency603034C1864233OMIM15422226603033
HP:0003199HP:0003199Decreased muscle mass0CPLX1 CL E G H108151941904p partial monosomy syndrome194190C1956097OMIM12062309605032
HP:0003199HP:0003199Decreased muscle mass0CTBP1 CL E G H14871941904p partial monosomy syndrome194190C1956097OMIM13522494602618
HP:0003199HP:0003199Decreased muscle mass0ECEL1 CL E G H9427615065Distal arthrogryposis type 5D615065C3554415OMIM12133147605896
HP:0003199HP:0003199Decreased muscle mass0FBN1 CL E G H2200154700Marfan syndrome154700C0024796OMIM166193603134797
HP:0003199HP:0003199Decreased muscle mass0FGFRL1 CL E G H538341941904p partial monosomy syndrome194190C1956097OMIM13963693605830
HP:0003199HP:0003199Decreased muscle mass0FUCA1 CL E G H2517349Neuroaxonal dystrophy renal tubular acidosisORPHA13084006612280
HP:0003199HP:0003199Decreased muscle mass0FUS CL E G H2521300605Juvenile amyotrophic lateral sclerosisCN239582ORPHA14744010137070
HP:0003199HP:0003199Decreased muscle mass0FUZ CL E G H801993027Iris dysplasia hypertelorism deafnessORPHA15726219610622
HP:0003199HP:0003199Decreased muscle mass0G6PC CL E G H2538232200Glycogen storage disease type 1A232200C2919796OMIM14056613742
HP:0003199HP:0003199Decreased muscle mass0GFPT1 CL E G H2673608931Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency608931C1837091OMIM15244241138292
HP:0003199HP:0003199Decreased muscle mass0GYG1 CL E G H2992263297ORPHA12734699603942
HP:0003199HP:0003199Decreased muscle mass0HERC2 CL E G H8924176270Prader-Willi syndrome176270C0032897OMIM19364868605837
HP:0003199HP:0003199Decreased muscle mass0HSD17B4 CL E G H3295261515Bifunctional peroxisomal enzyme deficiency261515C0342870OMIM19835213601860
HP:0003199HP:0003199Decreased muscle mass0IPW CL E G H3653176270Prader-Willi syndrome176270C0032897OMIM13026109601491
HP:0003199HP:0003199Decreased muscle mass0LAS1L CL E G H81887309585Wilson-Turner X-linked mental retardation syndrome309585C1839736OMIM128325726300964
HP:0003199HP:0003199Decreased muscle mass0LETM1 CL E G H39541941904p partial monosomy syndrome194190C1956097OMIM13676556604407
HP:0003199HP:0003199Decreased muscle mass0MAGEL2 CL E G H54551176270Prader-Willi syndrome176270C0032897OMIM110136814605283
HP:0003199HP:0003199Decreased muscle mass0MKRN3 CL E G H7681176270Prader-Willi syndrome176270C0032897OMIM13577114603856
HP:0003199HP:0003199Decreased muscle mass0MKRN3-AS1 CL E G H10108176270Prader-Willi syndrome176270C0032897OMIM112910603857
HP:0003199HP:0003199Decreased muscle mass0NDN CL E G H4692176270Prader-Willi syndrome176270C0032897OMIM13287675602117
HP:0003199HP:0003199Decreased muscle mass0NPAP1 CL E G H23742176270Prader-Willi syndrome176270C0032897OMIM13871190610922
HP:0003199HP:0003199Decreased muscle mass0NSD2 CL E G H74681941904p partial monosomy syndrome194190C1956097OMIM153812766602952
HP:0003199HP:0003199Decreased muscle mass0PANK2 CL E G H80025234200Pigmentary pallidal degeneration234200C0018523OMIM149915894606157
HP:0003199HP:0003199Decreased muscle mass0PIEZO2 CL E G H63895376ORPHA197826270613629
HP:0003199HP:0003199Decreased muscle mass0PIEZO2 CL E G H63895114300Gordon's syndrome114300C0220666OMIM197826270613629
HP:0003199HP:0003199Decreased muscle mass0PIEZO2 CL E G H63895248700Marden-Walker syndrome248700C0796033OMIM197826270613629
HP:0003199HP:0003199Decreased muscle mass0PIEZO2 CL E G H63895108145Oculomelic amyoplasia108145C1862472OMIM197826270613629
HP:0003199HP:0003199Decreased muscle mass0PTEN CL E G H5728744Aortic valves stenosis of the childORPHA130129588601728
HP:0003199HP:0003199Decreased muscle mass0PWAR1 CL E G H145624176270Prader-Willi syndrome176270C0032897OMIM130330089600161
HP:0003199HP:0003199Decreased muscle mass0PWRN1 CL E G H791114176270Prader-Willi syndrome176270C0032897OMIM131433235611215
HP:0003199HP:0003199Decreased muscle mass0RUSC2 CL E G H9853617773MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61617773C4540424OMIM182423625611053
HP:0003199HP:0003199Decreased muscle mass0SIGMAR1 CL E G H10280300605Juvenile amyotrophic lateral sclerosisCN239582ORPHA12478157601978
HP:0003199HP:0003199Decreased muscle mass0SMS CL E G H6611309583Snyder Robinson syndrome309583C0796160OMIM129411123300105
HP:0003199HP:0003199Decreased muscle mass0SNORD115-1 CL E G H338433176270Prader-Willi syndrome176270C0032897OMIM130533020609837
HP:0003199HP:0003199Decreased muscle mass0SNORD116-1 CL E G H100033413176270Prader-Willi syndrome176270C0032897OMIM130533067605436
HP:0003199HP:0003199Decreased muscle mass0SNRPN CL E G H6638176270Prader-Willi syndrome176270C0032897OMIM139611164182279
HP:0003199HP:0003199Decreased muscle mass0SPARC CL E G H6678616507Osteogenesis imperfecta, type xvii616507C4225301OMIM116811219182120
HP:0003199HP:0003199Decreased muscle mass0SPG11 CL E G H80208300605Juvenile amyotrophic lateral sclerosisCN239582ORPHA1262511226610844
HP:0003199HP:0003199Decreased muscle mass0TBC1D20 CL E G H128637615663Warburg micro syndrome 4615663C3810265OMIM119516133611663
HP:0003199HP:0003199Decreased muscle mass0TGFB3 CL E G H7043615582Loeys-Dietz syndrome 5615582C3810012OMIM155111769190230
HP:0003199HP:0003199Decreased muscle mass0TRIM2 CL E G H23321615490Charcot-Marie-Tooth disease, axonal, type 2R615490C3809655OMIM140415974614141
HP:0003199HP:0003199Decreased muscle mass0VANGL1 CL E G H818393027Iris dysplasia hypertelorism deafnessORPHA127815512610132
HP:0003199HP:0003199Decreased muscle mass0WHCR CL E G H74671941904p partial monosomy syndrome194190C1956097OMIM1127640
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0003199HP:0003199Decreased muscle mass0FSHB CL E G H2488229070Follicle-stimulating hormone deficiency, isolated229070C1856716OMIM0713964136530
HP:0003199HP:0003199Decreased muscle mass0MAP3K7 CL E G H6885617137Frontometaphyseal dysplasia 2617137C4310697OMIM02356859602614
HP:0003199HP:0003199Decreased muscle mass0MECP2 CL E G H4204778ORPHA019256990300005
HP:0003199HP:0003199Decreased muscle mass0POLG CL E G H5428298Mitochondrial neurogastrointestinal encephalomyopathyCN918676ORPHA023249179174763
HP:0003199HP:0003199Decreased muscle mass0RRM2B CL E G H50484298Mitochondrial neurogastrointestinal encephalomyopathyCN918676ORPHA035417296604712
HP:0003199HP:0003199Decreased muscle mass0SLC9A6 CL E G H1047985278ORPHA061211079300231
HP:0003199HP:0003199Decreased muscle mass0TYMP CL E G H1890298Mitochondrial neurogastrointestinal encephalomyopathyCN918676ORPHA08953148131222


Genes (56) :AKT1 ALS2 AP4E1 ASAH1 ATP6V0A2 ATP6V1A ATP6V1E1 CHRNE COLQ CPLX1 CTBP1 ECEL1 FBN1 FGFRL1 FSHB FUCA1 FUS FUZ G6PC GFPT1 GYG1 HERC2 HSD17B4 IPW LAS1L LETM1 MAGEL2 MAP3K7 MECP2 MKRN3 MKRN3-AS1 NDN NPAP1 NSD2 PANK2 PIEZO2 POLG PTEN PWAR1 PWRN1 RRM2B RUSC2 SIGMAR1 SLC9A6 SMS SNORD115-1 SNORD116-1 SNRPN SPARC SPG11 TBC1D20 TGFB3 TRIM2 TYMP VANGL1 WHCR

Diseases (34) :744 300605 613744 333 2834 357074 608931 603034 194190 615065 154700 229070 349 3027 232200 263297 176270 261515 309585 617137 778 234200 376 114300 248700 108145 298 617773 85278 309583 616507 615663 615582 615490
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is August 2021 release.